Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 24, 2024 10:32 ET
Xtract One Closes $7.2M Public Offering and $1.4M Investment by Strategic Partner
Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) announces that it has closed its previously announced public offering (the “Offering”) conducted by Eight Capital, as lead agent and sole bookrunner,...
Apr 24, 2024 10:31 ET
Class 1 Nickel Updates Resource Estimate on High-Grade Alexo South Nickel Sulphide Deposit – Significant Increases in Indicated and Inferred Resources Over the 2020 Estimate
Class 1 Nickel and Technologies Ltd. (CSE: NICO | OTCQB: NICLF) ("Class 1 Nickel" or the "Company") is pleased to announce an updated mineral resource estimate (“MRE”) for the Alexo South Nickel Deposit (“A-S Deposit”) (Table 1). The A-S Deposit,...
Apr 24, 2024 10:30 ET
BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) S
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that a late-breaking abstract with preliminary...
Apr 24, 2024 10:30 ET
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against bluebird bio, Inc. (“bluebird” or “the Company”) (NASDAQ: BLUE) for violations of §§10(b) and 20(a) of the Securities Exchange...
Apr 24, 2024 10:20 ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Evolv Technologies Holdings, Inc. with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. (“Evolv” or “the Company”) (NASDAQ: EVLV) for violations of...
Apr 24, 2024 10:18 ET
Global COVID-19 Memorial Will Honor Pandemic Frontline & Essential Workers
A monument park and website honoring medical frontline and essential workers worldwide who risked their lives during the COVID-19 pandemic will break ground this summer in Chicago, Illinois. The COVID-19 Monument of Honor, Remembrance, and...
Apr 24, 2024 10:18 ET
Granite Creek Announces Investment in The District Communications Group (DCG)
Granite Creek Capital Partners, in partnership with Boathouse Capital, today announced an investment in The District Communications Group (DCG), a full-service communications firm providing comprehensive market research and strategic communications...
Apr 24, 2024 10:11 ET
Fulcrum GT Renews Its Commitment to Els for Autism Foundation
Fulcrum GT, provider of the leading digital business platform for legal and professional services firms from new business inception through billing and finance operations to HCM and analytics, is proud to announce its continued commitment to...
Apr 24, 2024 10:10 ET
Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
Future Business Leaders of America, Inc. (FBLA), the nation’s largest career and technical student organization focused solely on business, invites business and technology professionals to build their workforce pipeline by volunteering during its...
Apr 24, 2024 10:09 ET
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advance
Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced that clinical data from its Phase 1 trial of CLN-619 in patients with advanced solid tumors will be presented...
Apr 24, 2024 10:08 ET
Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Gated Waterfront Living Experience in Freeport, New York
Blue Island Homes proudly announces its latest venture as the exclusive listing brokers for the final phase at Ocean Watch at Harbor Pointe, a luxurious waterfront development of 61 townhomes, located in Freeport, New York. This esteemed assignment...
Apr 24, 2024 10:06 ET
Juniata Valley Financial Corp. Announces Results for the Quarter Ended March 31, 2024
Juniata Valley Financial Corp. (OTCQX:JUVF) (“Juniata”), announced net income for the three months ended March 31, 2024 of $1.4 million, a decrease of 21.8%, compared to net income of $1.7 million for the three months ended March 31, 2023....
Apr 24, 2024 10:05 ET
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its oncology and hematology pipeline will be shared across 17 presentations at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, taking...
Apr 24, 2024 10:05 ET
Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New River Valley Plant
Volvo Trucks North America has announced a significant advancement in its sustainability efforts by fueling newly assembled trucks with Hydrotreated Vegetable Oil (HVO), a renewable fuel, as they depart from the Volvo Trucks New River Valley...
Apr 24, 2024 10:05 ET
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it will be presenting two abstracts, including an oral...
Apr 24, 2024 10:05 ET
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment...
Apr 24, 2024 10:02 ET
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8 antibody, at the upcoming ASCO Annual Meeting, which will be held from May 31 to June 4,...
Apr 24, 2024 10:01 ET
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that it will present an oral abstract and poster at...
Apr 24, 2024 10:00 ET
Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the abstract for longer-term follow-up and additional data analysis from the pivotal...
Apr 24, 2024 10:00 ET
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the acceptance of two abstracts for poster presentation at...